小RNA
伤口愈合
DNA
细胞生物学
化学
生物
基因
遗传学
生物化学
作者
Yulin Li,Zonghua Wang,Yueyan Dong,Xin Jin,Jingrao Wang,Hong Zhang
标识
DOI:10.1002/adhm.202304381
摘要
Abstract Corneal injury occurs frequently which may lead to serious visual impairment. Rapid and efficient re‐epithelialization after corneal epithelial injury is the key issue for maintaining corneal homeostasis. Among various treatment strategies, microRNA (miR)‐based therapy shows great potential. However, structural limitations of miRNAs hinder its biomedical functionality. Nucleic acid nanotechnology is an appealing candidate for gene delivery because of its flexible modification and excellent biocompatibility. Herein, modified 3D tetrahedral framework nucleic acids (tFNAs) utilized as gene carriers for miR‐21 delivery are constructed. TFNAs‐miR‐21 (T‐21) shows great enzymatic resistance in extracellular environment and payload delivery into human corneal epithelial cells (HCECs) via clathrin‐mediated endocytosis. T‐21 facilitates proliferation and migration in HCECs via activating PI3K/AKT and ERK1/2 signaling pathways in vitro. In vivo studies, T‐21 can be internalized by corneal epithelium in mice. In the mice corneal scratch model, T‐21 ophthalmic solutions used as eye drops show no apparent side effects on the ocular surface histologically and exert great potential in accelerating corneal wound healing. These findings demonstrate that modified tFNAs are promising candidates for miRNA delivery for corneal wound healing. The convenient administration and great biocompatibility of tetrahedral DNA nanoparticles highlight its potential as gene transporter in solving ocular problems.
科研通智能强力驱动
Strongly Powered by AbleSci AI